Galmed Pharmaceuticals logo

Galmed Pharmaceuticals (GLMD) Q2 2024 Earnings

GLMD·Reported August 28, 2024·Before market open

Diluted EPS came in at $2.16.

Diluted EPS
$2.16
SEC

SEC Filings

Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet

Filings will appear here once submitted to SEC EDGAR.

Q2 2024 Earnings FAQ

Common questions about Galmed Pharmaceuticals's Q2 2024 earnings report.

Galmed Pharmaceuticals (GLMD) reported Q2 2024 earnings on August 28, 2024 before market open.

Galmed Pharmaceuticals reported diluted EPS of $2.16 for Q2 2024.